Intera Atlas
Run match
Sites / Houston Methodist Research Institute
Is this you?

Request access for Houston Methodist Research Institute with your @houstonmethodist.org work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Houston Methodist Research Institute

Unclaimed profile

Academic Network · Houston, Texas · ~1 sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 7Lift (cardio sample) 0.15Recruit soph 0.57
Quality Scorecard (1–100)
Overall79Recruit67Ops81Sponsor88Ther84

Performance (observed)

Historical trials
379
Completed
156
Terminated/Withdrawn
40
Completion rate
80%
Active now
164
Phase 2
98
Phase 3
183
Realized enrollment
290,092
First study year
1999
Years active
27
Match confidence
high
Enrollment velocity (inf)
10,744

Therapeutic

Areas
Cancer, Heart & Vascular, Dementia, Bioengineering, Digital Health, AI, Cellular Therapeutics, Precision Medicine
Specialties
Cancer, heart/vascular, immunobiology, infectious disease, neuroscience, regenerative medicine, transplantation
Breadth (conditions)
812
Languages
English
States
Texas

Recruitment (web observed)

Trial Finder
Yes
Patient database
Y; 1,690+ clinical studies
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong; Comprehensive research and trials pages
Capability notes
Yes - Large hospital-based research infrastructure

Relationships

Sponsors
National Cancer Institute (NCI); AbbVie; Abbott Medical Devices; The Methodist Hospital Research Institute; Alliance for Clinical Trials in Oncology; Eli Lilly and Company
CROs
Acrotech Biopharma Inc.; Ethicon Endo-Surgery; Fortrea; IQVIA Biotech; IQVIA Pty Ltd; Microvention-Terumo, Inc.
Partnerships
TriNetX; Weill Cornell; Cockrell Center; 20+ core facilities
Owner / parent
Houston Methodist Hospital System; $90M+ extramural funding; 2,340 credentialed researchers
Funding
Academic medical center (nonprofit)
Expansion
Y; Multiple research centers and facilities
Recent hiring
Y; Research coordinators and clinical staff

Capacity & people

Investigators
—
Coordinators
—
CEO
Dr. Jenny C. Chang, MB.ChirB., MD, MCHM (President & CEO Academic Institute, Executive VP & Chief Academic Officer Houston Methodist)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
BSNClinicalTrials@bsci.com

Tech & DCT

CTMS
CTMS system in place
EHR
Epic
eSource
Yes
eConsent
Yes
Uses AI
Yes
Builds tech
Vendors and internal innovation (Johnson Center for Cellular Therapeutics, imaging labs)
DCT / decentralized
Y; TriNetX membership for real-world data
Tech stack
Digital health, AI platforms, imaging equipment, preclinical GLP/GMP facilities
Recruiting visible
Yes - 1,690+ clinical studies

Notes

ClinicalTrials.gov signal: 5 recruiting trials across 1 location(s), states: Texas. Major academic medical center with transformational research focus. Dr. Jenny Chang selected Jan 2025 as CEO after 15+ years, leading Dr. Mary and Ron Neal Cancer Center (top-20 ranked). Strong in platform technologies, bioengineering, digital health, cellular therapeutics. $35M+ in NIH/NCI funding. 2,000+ peer-reviewed publications. Academic structure but strong innovation and research volume.

Recommendation features (sample indication)

Ind fit 0.35Liftability 0.15Overall79

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.